WHO naming stem · infix · 19 listed names
-ster-
This page was written with AI.
Testosterone and finasteride are -ster- names; this page lists all 19 that WHO gives, with the brands each is sold under.
androgens/anabolic steroids
Where it sits in a name
WHO writes the stem as -ster-. So the letters ster sit inside the name, with letters before and after it (…ster…).
All 19 names WHO lists under -ster-
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 6 of 19 names appear in these lists: 6 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 5 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- bexlosterideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bolasteroneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cloxotestosteroneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dutasterideUS brands: AVODARTEU (central) brands: none found
- epristerideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- finasterideEU (central) brands: none found
- fluoxymesteroneUS brands: ANDROID-F (discontinued in FDA listings), HALOTESTIN (discontinued in FDA listings), ORA-TESTRYL (discontinued in FDA listings)EU (central) brands: none found
- izonsterideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lapisterideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mesteroloneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- methyltestosteroneUS brands: ANDROID 10 (discontinued in FDA listings), ANDROID 25 (discontinued in FDA listings), ANDROID 5 (discontinued in FDA listings), METANDREN (discontinued in FDA listings), ORETON (discontinued in FDA listings), ORETON METHYL (discontinued in FDA listings), TESTRED (discontinued in FDA listings), VIRILON (discontinued in FDA listings)EU (central) brands: none found
- oxymesteroneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- penmesterolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prasteroneUS brands: INTRAROSAEU (central) brands: Intrarosa
- rosteroloneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- testosteroneUS brands: ANDROGEL, NATESTO, TESTIM, TESTOPEL, VOGELXO, ANDRODERM (discontinued in FDA listings), AXIRON (discontinued in FDA listings), FORTESTA (discontinued in FDA listings), STRIANT (discontinued in FDA listings), TESTODERM (discontinued in FDA listings), TESTODERM TTS (discontinued in FDA listings)
- testosterone ketolaurateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tiomesteroneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- turosterideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not androgens/anabolic steroids
WHO lists these 18 names under -ster-, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of -ster- does not apply.
- aldosteroneWHO’s note: corticosteroid
- azacosterolWHO’s note: hypocholesterolemic
- calusteroneWHO’s note: antineoplastic
- dihydrotachysterolWHO’s note: antihypoparathyroid
- dimethisterone
- dydrogesterone
- ethisterone
- haloprogesterone
- hydroxyprogesterone
- larsucosterol
- medroxyprogesterone
- nisterimeWHO’s note: contraceptive agent
- norethisterone
- norgesterone
- norvinisterone
- progesterone
- segesterone
- stercuronium iodideWHO’s note: neuromuscular blocking agent
Decode another name
Decoded
prasterone
Listed INNCarries 2 WHO stems, most specific first: -terone …
- -teroneend of the nameWHO definition: antiandrogens
- -ster-inside the nameWHO lists it hereWHO definition: androgens/anabolic steroids
“prasterone” is an INN that WHO lists under -ster- in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -ster- (Part II B) and the 19 names (Part IV, group (a)), and the 18 not in accordance with it (group (b)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.